The company manufactures and sells artificial flowers, plants, and wedding decor accessories to event planners and retail customers through wholesale showrooms and a growing franchise network.
The company lacks a wide moat, as artificial decor is a fragmented market with low barriers to entry and high susceptibility to design imitation. While high ROCE suggests some efficiency, the negative cash conversion indicates that growth is being funded by stretching working capital rather than durable pricing power or cost advantages.
Earnings are primarily reinvested into expanding manufacturing capacity in Gujarat and building out a retail/franchise footprint. While growth is high, the heavy investment in inventory and fixed assets has resulted in negative free cash flow, necessitating recent increases in debt.
The company’s aggressive expansion into Dubai and domestic retail collapsed under the weight of its own working capital requirements. By 2029, the negative cash conversion cycle—already visible in 2024—became a terminal drain as inventory for 8,700+ SKUs grew faster than sales. The reliance on the fickle wedding industry proved fatal when consumer tastes shifted away from artificial decor, leaving the company with mountains of obsolete stock and a debt-to-equity ratio that spiraled out of control as interest coverage evaporated.
RichFakir rates Interiors & More Ltd's business quality as poor — 43/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Interiors & More Ltd is trading about 40% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Interiors & More Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Interiors & More Ltd's fair value is about ₹97 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →